Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

HS-10382

1 clinical trial

3 indications

Indication
Chronic Myeloid Leukemia
Indication
Chronic Phase
Indication
Accelerated Phase
Clinical trial
A Phase I, Open-label, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Single and Multiple Doses of Oral Administration of HS-10382 in Patients With Chronic Myeloid Leukemia.
Status: Recruiting, Estimated PCD: 2024-12-30